DHR monthly performance report
Check DHR's monthly returns, drawdown, and seasonality trends — updated every month.
DHR monthly report
—
Key takeaways
- Danaher Corporation (DHR) closed November 2026 at $232.16, down 0.03% for the month and +5.82% over the trailing 12 months.
- Year-to-date, DHR is +1.42%, underperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +15.39% versus its 200-day moving average ($201.19), a bullish technical signal.
- Over the past three years, DHR has underperformed the S&P 500 by −53.99%, with a relative strength index reading of 68.9.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Danaher Corporation ended November 2026 at $232.16, posting a monthly return of −0.03%. The S&P 500 returned +0.19% over the same window, leaving relative performance at −0.22%.
The current quarter stands at +4.79% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +15.39% versus the 200-day moving average ($201.19).
Year-to-date, DHR is +1.42% against SPY +11.03%, a gap of −9.61%. The stock is currently −4.38% below its 52-week high, with maximum 3-year drawdown at −42.33%.
| Period | DHR | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.34% | −0.35% | −0.98% |
| 1 Week | +2.57% | +3.29% | −0.72% |
| 1 Month | −0.03% | +0.19% | −0.22% |
| 3 Months | +14.68% | −2.48% | +17.15% |
| 6 Months | +39.86% | +2.00% | +37.87% |
| YTD | +1.42% | +11.03% | −9.61% |
| 12 Months | +5.82% | +10.79% | −4.97% |
| 3 Years | +17.85% | +71.83% | −53.99% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2023 | +16.30% |
| #2 | Jul 2024 | +10.90% |
| #3 | Aug 2026 | +9.53% |
| #4 | Oct 2025 | +8.64% |
| #5 | Feb 2024 | +5.51% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −12.70% |
| #2 | Oct 2024 | −11.64% |
| #3 | Mar 2026 | −9.99% |
| #4 | Feb 2025 | −6.73% |
| #5 | Sep 2023 | −6.38% |
| Quarter | Return |
|---|---|
| Q3 2025 | +0.36% |
| Q4 2025 | +15.46% |
| Q1 2026 | −17.18% |
| Q2 2026 | +0.46% |
| Q3 2026 | +16.31% |
| Q4 2026 (QTD) | +4.79% |
| Year | Return |
|---|---|
| 2023 | −1.68% |
| 2024 | −0.77% |
| 2025 | −0.27% |
| 2026 | +1.42% |
| Metric | Value |
|---|---|
| 52-Week High | $242.80 (2026-01-22) |
| 52-Week Low | $160.93 (2026-05-15) |
| Current Price | $232.16 |
| 200-Day Moving Average | $201.19 |
| Price vs 200DMA | +15.39% |
| 3-Year Maximum Drawdown | −42.33% (2026-05-15) |
| Current Drawdown from 52W High | −4.38% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 68.9 |
| 3-Year Excess Return vs S&P 500 | −53.99% |
| RS Peak | 116.9 (Aug 2024) |
| RS Trough | 49.2 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DHR's return for this report period?
DHR returned −0.03% in the latest monthly window ending 2026-11-12.
Has DHR outperformed SPY year to date?
YTD DHR: +1.42% vs SPY: +11.03%.
What is DHR's 12-month return?
+5.82% over the trailing 12 months.
Is DHR above or below its 200-day moving average?
Price is +15.39% versus 200DMA ($201.19).
What is the maximum drawdown in the 3-year window?
−42.33% on 2026-05-15.